Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
João Soares Nunes(Hammersmith Hospital), Dmitri Pchejetski(University of East Anglia), Hector C. Keun(Imperial College London), Justin Sturge(University of Hull), Maria Naymark(The London College), Lysann Sauer(Centre National de la Recherche Scientifique), Jonathan Waxman, Justin Stebbing(Anglia Ruskin University), Aun Muhammad(Whittington Hospital)
Cited by 57
Related Papers
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
|Nature Protocols|2007|2.1k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
|Toxicology and Applied Pharmacology|2003|386
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268